Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 06, 2016 11:28 PM ET

Pharmaceuticals

Company Overview of GlaxoSmithKline Pakistan Ltd.

Company Overview

GlaxoSmithKline Pakistan Limited manufactures and markets research based ethical specialties, other pharmaceutical, and consumer products in Pakistan and internationally. It operates through two segments, Pharmaceuticals and Consumer healthcare. The company deals in anti-infective, respiratory, vaccines, dermatological, analgesics, oncology, urology, central nervous system, allergy, cardiovascular, and vitamins therapy areas. It offers its pharmaceutical products primarily under the Augmentin, Seretide, Amoxil, Velosef, Zantac, and Calpol brands; consumer healthcare products under the Panadol, Horlicks, Sensodyne, and ENO brands; and vaccines under the Synflorix, Infanrix Hexa, Rotarix, Havr...

35, Dockyard Road

West Wharf

Karachi,  74000

Pakistan

2,514 Employees

Phone:

92 21 111 475 725

Fax:

92 21 323 14898

Key Executives for GlaxoSmithKline Pakistan Ltd.

GlaxoSmithKline Pakistan Ltd. does not have any Key Executives recorded.

GlaxoSmithKline Pakistan Ltd. Key Developments

GlaxoSmithKline Pakistan Announces Executive Changes

GlaxoSmithKline Pakistan Ltd. announced that Mr. M Salman Burney, Chief Executive Officer shall officially retire from the company on November 21, 2015 and will cease to hold the office of CEO. Consequently the board of directors have appointed Mr. Mohammed Azizul Huq as Chief Executive Officer effective November 22, 2015.

GlaxoSmithKline Pakistan Ltd., Special/Extraordinary Shareholders Meeting, Nov 30, 2015

GlaxoSmithKline Pakistan Ltd., Special/Extraordinary Shareholders Meeting, Nov 30, 2015. Agenda: To pass special resolution for demerger of business comprising all assets, rights, quotas& obligations of consumer healthcare business of GSK Pakistan with & into GlaxoSmithKline Consu.Healthcare.

GlaxoSmithKline Pakistan Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015

GlaxoSmithKline Pakistan Ltd. reported earnings results for the third quarter and nine months ended September 30, 2015. For the quarter, the company reported sales of PKR 5,902.1 million compared to PKR 5,740.1 million, profit from operations of PKR 1,533.4 million compared to PKR 635.0 million, profit before taxation of PKR 1,489.2 million compared to PKR 629.1 million and profit after taxation of PKR 1,298.7 million or PKR 4.08 per share compared to PKR 400.0 million or PKR 1.26 per share for the last year. For the nine months, the company reported sales of PKR 17,676.7 million compared to PKR 17,022.0 million, profit from operations of PKR 2,753.9 million compared to PKR 1,831.1 million, profit before taxation of PKR 2,699.9 million compared to PKR 1,831.1 million and profit after taxation of PKR 2,131.6 million or PKR 6.69 per share compared to PKR 1,192.7 million or PKR 3.75 per share for the last year.

Similar Private Companies By Industry

Company Name Region
Macter International Limited Middle East/Africa
Hilton Pharma (Pvt) Ltd. Middle East/Africa
AGP (Private) Limited Middle East/Africa
GlaxoSmithKline Consumer Healthcare Pakistan Limited Middle East/Africa
Ray Pharma (Pvt.) Limited Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
Spin-Off/Split-Off
August 25, 2015
GlaxoSmithKline Consumer Healthcare Pakistan Limited
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GlaxoSmithKline Pakistan Ltd., please visit www.gsk.com.pk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.